About us

McSAF is a Deeptech company specialized in Bio-Organic & Bio-Conjugates Chemistry, developing innovative technologies for improved targeted therapies.

Who we are

With a multidisciplinary approach on bio-organic chemistry, medicinal & bio-conjugates chemistry, site specific conjugation, our team rich of a wide diversity of scientific profiles and personalities, can also rely on a first order excellence network, both on academic & industrial side, which is regularly enriched by collaborative R&D programs and strategic alliances.

Aiming to maintain long-term relationships with our customers, being closer to their needs, we believe in innovation and pay particular attention to answer specific needs by providing customized solutions with high quality standards.

Techno-provider
Our technologies and know-how guarantee the homogeneity and the stability of your products and the repeatability of your processes.
PROPRIETARY TECHNOLOGY
Antibody Drug Conjugates: DAR 1 / DAR 2 / DAR 4
Site-Specific
DAR Control
Native antibody
Reproducible process
OWN R&D
Chemical Tools for Bio-Conjugates & Selective Synthesis
Antibody Drug Conjugates

Our values

• Scientific rigor
Our evidence-based approach is key to creating the next-generation products of medicine.
• Enthusiasm
We know that we are moving towards safer and more efficient therapies for patients.

• Solidarity
We want to develop treatments for diseases that touch everyone’s life.
• Passion
We believe in the potential of our work to change lives.

Our commitment

Illness is something that touches everyone’s life at some point, and our researchers are no exception to this. It is easy for us to be passionate in our work when we are involved in medical breakthroughs that have the potential to one day treat our families and our friends. We are excited to participate in the development of new solutions to improve patient quality of care, to support doctors in the optimization of treatment, and to give patients the best possible chance to fight disease. Our dedication, energy, and hard work comes from our commitment to this goal.

#connected to medical need

Our vision

Our innovations in the field of ADCs have inspired us to contribute to the continued improvement of this cancer treatments, as well as extending the use of ADCs beyond oncology in the near future. We are proud that our work is synonymous with scientific and medical progress to improve patient service and increase quality of care.

#connected to innovation

Our mission

Through our passion and our entrepreneurial spirit, we are dedicated to the discovery and development of new solutions to fight diseases, create new drugs, improve patient quality of life, and ensure a healthier future for people.

McSAF is a Deeptech company specialized in Bio-Organic & Bio-Conjugates Chemistry, developing innovative technologies for improved targeted therapies.

Who we are

McSAF is located in Tours

7 patent families

Technologies and products

Validation of our DAR 4 technology

On 3 preclinical models in oncology

Techno-provider

PROPRIETARY TECHNOLOGY

OWN R&D

Our values

• Scientific rigor

• Enthusiasm

• Solidarity

• Passion

Our commitment

#connected to medical need

Our vision

#connected to innovation

Our mission

#connected to a healthy future

New publication in Bioconjugate Chemistry

New publication in British Journal of Dermatology

McSAF and Novasep announce their successful collaboration to produce a next-generation Antibody-Drug Conjugate (ADC)

McSAF Inside® Oncology selected in the Top100 of start-up to fund in 2021

New publication in Bioconjugate Chemistry

Press Release: The European Patent Office has granted McSAF a patent for DAR 4 antibody-drug conjugates technology

McSAF recrute un(e) Technicien(ne) R&D

Meet us at next World ADC Summit, London, 5-6th March 2019

Meet us at 5th Antibody Industrial Symposium, June 27-28, Tours – France

Interesting links

Pages

Archive